Respiri Ltd (ASX: RSH) Share Price and News

Price

Movement

( )

(20 mins delayed)

52 Week Range

-

 
1 Year Return

 

Respiri Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $60.10 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 1.50 billion
Earnings per share -0.007
Dividend per share N/A
Year To Date Return -51.81%
Earnings Yield N/A
Franking -
Share Price

Day Change

( )

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

  • Should you invest $1,000 in Respiri Limited right now?

    Before you buy Respiri Limited shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Respiri Limited wasn't one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys...

    See The 5 Stocks *Returns as of 6 March 2025

  • Respiri Ltd (ASX: RSH)
    Latest News

    Doctor doing a telemedicine using laptop at a medical clinic
    Healthcare Shares

    3 ASX healthcare shares surging on big news

    The ASX healthcare sector is higher on Tuesday and these stocks are among the strongest performers.

    Read more »

    RSH ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size

    About Respiri Ltd

    Respiri Ltd is a company engaged in the research, development, and commercialization of medical devices and the production of mobile health applications for the management of asthma and related chronic respiratory diseases. It operates through the following segments: The Australia segment includes research, development, and commercialisation of medical devices, and the production of mobile health applications in Australia. The company generates revenue through Medical Devices Segment in Australia.

    RSH Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    07 Mar 2025 $0.04 $0.00 0.00% 2,163,981 $0.04 $0.04 $0.04
    06 Mar 2025 $0.04 $0.00 0.00% 1,835,537 $0.05 $0.05 $0.04
    05 Mar 2025 $0.05 $0.00 0.00% 1,359,099 $0.05 $0.05 $0.04
    04 Mar 2025 $0.05 $0.00 0.00% 1,039,759 $0.05 $0.05 $0.05
    03 Mar 2025 $0.05 $0.00 0.00% 2,403,081 $0.04 $0.05 $0.04
    26 Feb 2025 $0.05 $0.00 0.00% 60,120 $0.05 $0.05 $0.05
    25 Feb 2025 $0.05 $0.00 0.00% 741,351 $0.05 $0.05 $0.04
    24 Feb 2025 $0.05 $0.00 0.00% 919,732 $0.05 $0.05 $0.05
    21 Feb 2025 $0.05 $-0.01 -18.18% 2,672,583 $0.05 $0.05 $0.05
    20 Feb 2025 $0.06 $0.00 0.00% 338,387 $0.05 $0.06 $0.05
    19 Feb 2025 $0.06 $0.00 0.00% 320 $0.06 $0.06 $0.05
    18 Feb 2025 $0.06 $0.00 0.00% 173,126 $0.06 $0.06 $0.06
    17 Feb 2025 $0.06 $0.00 0.00% 279,956 $0.06 $0.06 $0.06
    14 Feb 2025 $0.06 $0.00 0.00% 992,679 $0.06 $0.06 $0.05
    13 Feb 2025 $0.06 $0.00 0.00% 445,964 $0.06 $0.06 $0.06
    12 Feb 2025 $0.06 $0.00 0.00% 483,673 $0.06 $0.06 $0.05
    11 Feb 2025 $0.06 $0.00 0.00% 1,678,577 $0.06 $0.06 $0.06
    10 Feb 2025 $0.06 $-0.01 -14.93% 511,665 $0.07 $0.07 $0.06
    07 Feb 2025 $0.07 $0.00 0.00% 25,695 $0.07 $0.07 $0.07

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    30 Sep 2024 Marjan Mikel Expiry 15,000,000 $540,000
    Options expired.
    30 Sep 2024 Nicholas Smedley Expiry 10,000,000 $360,000
    Options expired.
    01 May 2024 Marjan Mikel Issued 30,000,000 $960,000
    Issue of options.
    01 May 2024 Nicholas Smedley Issued 30,000,000 $960,000
    Issue of options.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Marjan Mikel Executive DirectorChief Executive OfficerManaging Director Nov 2019
    Mr Mikel is a managing director and board member with a career spanning Australia, Europe and Japan, Marjan's focus has been in the healthcare industry, from pharmaceuticals and information services and technology to medical devices and sleep disorder solutions. He founded and subsequently sold Healthy Sleep Solutions after developing it into a business, with Resmed Ltd as a joint venture/shareholder partner.
    Mr Nicholas Smedley Executive ChairmanExecutive Director Oct 2019
    Mr Smedley is an Investment Banker and M&A Advisor, with 14 years of experience at UBS and KPMG. He has worked on M&A transactions in the UK, Hong Kong, China, and Australia with transactions ranging from the A$9bn defence of WMC Resources through to the investment of $65m into Catch.com.au. Nicholas currently oversees investments in the Property, Aged care, Technology and Medical Technology space. Key areas of expertise include M&A, Debt structuring, corporate governance and innovation.
    Mr Jonathan Adams Non-Executive Director Feb 2025
    Mr Adams currently serves as an Investment Director at Mt. Vernon Investments, LP. Mr Adams joined Mt. Vernon Investments in 2007 and is primarily responsible for sourcing, structuring, and executing private equity and venture capital investments across direct, co-investments, and select fund investments. Prior to joining Mt. Vernon Investments, Mr Adams was an accountant at PricewaterhouseCoopers. Mr Adams served as Chairman of the Board for Orb Health, Inc. and also serves as a Board Director for TTI Acquisition, LLC, parent company of TTI Sports International. Mr Adams serves as a Board Observer for multiple portfolio company investments of Mt. Vernon Investments.
    Mr Justin Mouchacca Joint Company Secretary Jan 2024
    -
    Ms Nova Taylor Joint Company Secretary Jan 2024
    -
    Justin Mouchacca Joint Company Secretary
    -
    Nova Taylor Joint Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Bnp Paribas Nominees Pty Ltd <Hub24 Custodial Serv Ltd> 56,697,058 4.41%
    Citicorp Nominees Pty Limited 50,338,143 3.92%
    Bt Portfolio Services Ltd <Rooney Pension Fund A/C> 44,211,033 3.44%
    Bt Portfolio Services Limited <Mr Thien Foo Ko A/C> 23,699,718 1.84%
    Mallamanda Pty Ltd <Mallamanda A/C> 22,100,000 1.72%
    Mr Peter Karl Braun 20,000,000 1.56%
    David James and Rosemary James <James Superannuation Fund Ac> 18,032,352 1.40%
    Bond Street Custodians Limited <Benri2 V85380 A/C> 18,026,140 1.40%
    Bt Portfolio Services Ltd <Miss Lucia Ippoliti A/C> 17,333,333 1.35%
    Bt Portfolio Services Ltd <Mr Gabriel Ippoliti A/C> 16,750,000 1.30%
    Mr John Anthony Dell 16,666,667 1.30%
    Mrs Tara Marjorie Hill 16,666,667 1.30%
    Bt Portfolio Services Limited <Krishnan Roodenrys Fsf A/C> 16,108,864 1.25%
    System Architects International Nominees Pty Ltd <Sai Super A/C> 14,943,125 1.16%
    Bt Portfolio Services Limited <Kyrelle S/F A/C> 14,810,784 1.15%
    Gemjill Pty Ltd <Ehsman Stuckey S/F A/C> 14,100,000 1.10%
    Mr Simon Dumaresq and Dr Belinda Jackson <Dumason A/C> 13,497,223 1.05%
    Bt Portfolio Services Limited <Mcewen Family S/F A/C> 13,333,334 1.04%
    Bt Portfolio Services Limited <Mcewen Family S/F A/C> i 12,265,193 0.95%
    Netwealth Investments Limited <Super Services A/C> 11,465,686 0.89%

    Profile

    since

    Note